Study findings suggest the potential to repurpose a drug that is FDA-approved for treating asthma and eczema, to enhance ...

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their ...

New study reveals how ovarian cancer shields itself from the immune system, opening doors to innovative immunotherapy methods ...

Fresh from news of a “complete response” from other clinical trials last week, Imugene has now dosed the first patient with a ...

Weill Cornell Medicine researchers have discovered a way ovarian tumors cripple immune cells: by tampering with their ability ...

The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.

Some studies have shown that Keytruda may be beneficial for a certain type of ovarian cancer. This was seen when Keytruda was used either alone or together with other cancer drugs. But more ...

In a major leap toward more effective cancer treatments, researchers at the University of Oulu have developed an innovative pipeline designed to directly analyze drug responses in primary patient ...

Citation: Study finds eczema-linked protein helps ovarian cancer survive, suggesting potential for skin drug-based treatment (2024, October 30) retrieved 7 November 2024 from https://medicalxpress ...

The University of Iowa has been selected among 22 other research teams to participate in the Advanced Research Projects ...

platinum-resistant primary ovarian cancer. Filippos Vingopoulos, MD Drug-related corneal toxicity occurred in 69% of eyes, ...

Verastem Oncology submits NDA to US FDA for avutometinib plus defactinib to treat recurrent KRAS mutant low-grade serous ovarian cancer: Boston Monday, November 4, 2024, 14:00 Hrs ...